Research

The FDA has approved Kymriah, the first CAR T-cell therapy for acute lymphoblastic leukemia. Find out how St. Jude is planning to use this novel treatment.

Find out how a newly discovered protein can give your body’s doomed cells a second chance at life.

St. Jude scientists, in work published in the journal Neuron, used powerful analytical tools to map what is known as the “epigenetics” of the retina.

Is Ptpn6, a controlling gene, linked with the master immune switch IL-1 alpha? Can this link be mapped to help pinpoint immune system response? Find out more.

NIH seminar elucidates new guidelines for grant-funded research as well as allocation of monies to more labs.

Find out how to access GWAS data from the Childhood Cancer Survivor Study, to help answer how genetics.

Zebrafish and humans are surprisingly alike when it comes to blood stem cells. Find out how studying zebrafish led to advancements in treating blood disorders.

Learn how AACR and St. Jude offer opportunities for pediatric cancer researchers to collaborate and share resources.

Recent research uncovers new information regarding the role Ezh2 plays in medulloblastoma development. Learn more about the study results.

These inherited gene variations may help explain why the risk of relapse for children with acute lymphoblastic leukemia varies by race.